510(k) K132082
K132082 is an FDA 510(k) premarket notification submitted by Aesku Diagnostics for the device "AESKULISA DGP-A, AESKULISA DGP-G,AESKULISA DGP-CHECK". The FDA issued a decision of Substantially Equivalent on December 5, 2013. The device falls under product code MST (Antibodies, Gliadin), a Class II device regulated under 21 CFR 866.5750. Aesku Diagnostics has at least 8 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- December 5, 2013
- Date Received
- July 5, 2013
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Antibodies, Gliadin
- Device Class
- Class II
- Regulation Number
- 866.5750
- Review Panel
- IM
- Submission Type